Claforan, Cefotaxime Sodium
| General Information: Antibiotic |
| |
|
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Hospira |
Claforan (Cefotaxime
Sodium) |
1g ADD-Vantage |
00039-0023-25 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
1g ADD-Vantage |
00039-0023-50 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
1g PGBK Vial |
00039-0018-11 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
1g Vial |
00039-0018-10 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
1g Vial |
00039-0018-25 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
1g Vial |
00039-0018-50 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
10g BTL |
00039-0020-01 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g ADD-Vantage |
00039-0024-25 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g ADD-Vantage |
00039-0024-50 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g PGBK Vial |
00039-0019-11 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g Vial |
00039-0019-10 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g Vial |
00039-0019-25 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
2g Vial |
00039-0019-50 |
PI |
MSDS |
|
|
Claforan (Cefotaxime
Sodium) |
500 mg vial |
00039-0017-10 |
PI |
MSDS |
|
| |
|
| Clinical Data:
For any questions or for further information related to Claforan,
Cefotaxime Sodium,
clinical pharmacology, additional indications and usages,
contraindications, warnings, precautions, adverse reactions, dosage,
administration and/or storage of this product, please
contact BDI Pharma or
call 1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|